
Select Medical (SEM) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
1.4B
Gross Profit
180.6M
13.34%
Operating Income
112.7M
8.33%
Net Income
74.7M
5.52%
EPS (Diluted)
$0.44
Balance Sheet Metrics
Total Assets
5.6B
Total Liabilities
3.6B
Shareholders Equity
2.0B
Debt to Equity
1.81
Cash Flow Metrics
Operating Cash Flow
129.4M
Free Cash Flow
62.0M
Revenue & Profitability Trend
Select Medical Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 5.2B | 6.7B | 6.3B | 6.2B | 5.5B |
Cost of Goods Sold | 4.6B | 5.7B | 5.6B | 5.3B | 4.7B |
Gross Profit | 633.6M | 932.0M | 733.4M | 919.4M | 821.3M |
Gross Margin % | 12.2% | 14.0% | 11.6% | 14.8% | 14.8% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 225.9M | 170.2M | 153.0M | 147.0M | 138.0M |
Other Operating Expenses | -3.4M | -1.8M | -28.8M | -144.0M | -90.0M |
Total Operating Expenses | 222.5M | 168.4M | 124.3M | 2.9M | 48.0M |
Operating Income | 268.3M | 554.9M | 403.3M | 713.8M | 567.7M |
Operating Margin % | 5.2% | 8.3% | 6.4% | 11.5% | 10.3% |
Non-Operating Items | |||||
Interest Income | - | 0 | 0 | 5.4M | 0 |
Interest Expense | 128.6M | 198.6M | 169.1M | 136.0M | 153.0M |
Other Non-Operating Income | 35.1M | 26.1M | 26.4M | 46.6M | 41.8M |
Pre-tax Income | 174.8M | 382.4M | 260.6M | 629.7M | 456.5M |
Income Tax | 44.8M | 82.6M | 62.6M | 129.8M | 111.9M |
Effective Tax Rate % | 25.6% | 21.6% | 24.0% | 20.6% | 24.5% |
Net Income | 296.7M | 299.7M | 198.0M | 499.9M | 344.6M |
Net Margin % | 5.7% | 4.5% | 3.1% | 8.1% | 6.2% |
Key Metrics | |||||
EBITDA | 536.1M | 804.4M | 635.5M | 966.2M | 802.8M |
EPS (Basic) | $1.66 | $1.91 | $1.23 | $2.98 | $1.93 |
EPS (Diluted) | $1.66 | $1.91 | $1.23 | $2.98 | $1.93 |
Basic Shares Outstanding | 124628000 | 123105000 | 122511000 | 130249000 | 129780000 |
Diluted Shares Outstanding | 124628000 | 123105000 | 122511000 | 130249000 | 129780000 |
Income Statement Trend
Select Medical Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 59.7M | 84.0M | 97.9M | 74.3M | 577.1M |
Short-term Investments | 0 | 59.0M | 74.9M | 0 | - |
Accounts Receivable | 821.4M | 940.3M | 941.3M | 889.3M | 896.8M |
Inventory | - | - | - | - | - |
Other Current Assets | 112.1M | 151.6M | 125.4M | 120.2M | 114.5M |
Total Current Assets | 1.0B | 1.3B | 1.3B | 1.1B | 1.6B |
Non-Current Assets | |||||
Property, Plant & Equipment | 908.1M | 1.2B | 1.2B | 1.1B | 1.0B |
Goodwill | 4.8B | 7.4B | 7.3B | 7.3B | 7.1B |
Intangible Assets | 103.2M | 329.9M | 351.7M | 374.9M | 387.5M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 372.8M | 376.7M | 341.7M | 338.7M | 319.2M |
Total Non-Current Assets | 4.6B | 6.4B | 6.4B | 6.2B | 6.1B |
Total Assets | 5.6B | 7.7B | 7.7B | 7.4B | 7.7B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 142.2M | 174.3M | 186.7M | 233.8M | 177.1M |
Short-term Debt | 225.7M | 346.0M | 313.1M | 289.3M | 233.0M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | - |
Total Current Liabilities | 977.7M | 1.2B | 1.2B | 1.3B | 1.4B |
Non-Current Liabilities | |||||
Long-term Debt | 2.5B | 4.6B | 4.8B | 4.5B | 4.3B |
Deferred Tax Liabilities | 81.5M | 143.3M | 169.8M | 142.8M | 132.4M |
Other Non-Current Liabilities | 73.0M | 110.3M | 106.1M | 106.4M | 168.7M |
Total Non-Current Liabilities | 2.6B | 4.9B | 5.1B | 4.7B | 4.6B |
Total Liabilities | 3.6B | 6.1B | 6.3B | 6.0B | 6.0B |
Equity | |||||
Common Stock | 129.0K | 128.0K | 127.0K | 134.0K | 135.0K |
Retained Earnings | 770.1M | 751.9M | 581.0M | 593.3M | 553.2M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 2.0B | 1.6B | 1.4B | 1.4B | 1.7B |
Key Metrics | |||||
Total Debt | 2.7B | 5.0B | 5.2B | 4.8B | 4.5B |
Working Capital | 42.1M | 9.2M | 116.2M | -133.6M | 155.6M |
Balance Sheet Composition
Select Medical Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 296.7M | 299.7M | 198.0M | 499.9M | 344.6M |
Depreciation & Amortization | 203.9M | 208.7M | 205.8M | 202.6M | 205.7M |
Stock-Based Compensation | 100.7M | 43.8M | 37.8M | 30.9M | 27.2M |
Working Capital Changes | -81.6M | -24.6M | -172.4M | -256.8M | 310.3M |
Operating Cash Flow | 490.2M | 514.2M | 279.0M | 484.0M | 875.2M |
Investing Activities | |||||
Capital Expenditures | -222.2M | -229.2M | -190.4M | -180.5M | -146.4M |
Acquisitions | -13.1M | -39.4M | -44.3M | -102.9M | -52.2M |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | -231.0M | -268.5M | -226.3M | -256.6M | -115.4M |
Financing Activities | |||||
Share Repurchases | -37.9M | -12.8M | -195.5M | -79.5M | -16.0M |
Dividends Paid | -64.6M | -63.9M | -64.6M | -50.6M | 0 |
Debt Issuance | 4.3B | 3.0B | 1.1B | 193.0M | 40.1M |
Debt Repayment | -4.8B | -3.2B | -881.0M | -39.7M | -558.2M |
Financing Cash Flow | -315.6M | -329.2M | -45.3M | -647.4M | -1.1B |
Free Cash Flow | 295.7M | 352.9M | 94.5M | 220.7M | 881.6M |
Net Change in Cash | -56.5M | -83.4M | 7.4M | -420.0M | -381.7M |
Cash Flow Trend
Select Medical Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
23.21
Forward P/E
6.37
Price to Book
1.07
Price to Sales
0.35
PEG Ratio
6.37
Profitability Ratios
Profit Margin
3.33%
Operating Margin
8.33%
Return on Equity
7.72%
Return on Assets
2.42%
Financial Health
Current Ratio
1.16
Debt to Equity
136.22
Beta
1.20
Per Share Data
EPS (TTM)
$0.62
Book Value per Share
$13.40
Revenue per Share
$41.69
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
sem | 1.8B | 23.21 | 1.07 | 7.72% | 3.33% | 136.22 |
HCA Healthcare | 94.2B | 16.91 | -76.81 | 13,631.68% | 8.21% | -37.45 |
Tenet Healthcare | 15.7B | 11.18 | 4.20 | 29.65% | 7.18% | 158.70 |
Acadia Healthcare | 1.9B | 13.80 | 0.62 | 4.83% | 4.31% | 74.74 |
Pacs | 1.8B | 19.41 | 3.15 | 110.96% | 2.59% | 469.36 |
Ardent Health | 1.8B | 6.57 | 1.44 | 24.32% | 4.11% | 138.17 |
Financial data is updated regularly. All figures are in the company's reporting currency.